Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Propionibacterium Acnes Keratitis

B. Ovodenko; M. Shah; R.J. Yang; D.C. Ritterband; J.A. Seedor; R.S. Koplin

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4753. doi:

ARVO Annual Meeting Abstract May 2006

Corneal Ulceration in Rural Sierra Leone

J.A. Capriotti; D.M. Caivano; M. Shah; D.C. Ritterband

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1910. doi:

ARVO Annual Meeting Abstract May 2006

Could Voriconazole Be a Safe and Effective Additive to Optisol GS® Cornea Storage Media to Prevent Fungal Contamination?

R.J. Yang; D.C. Ritterband; M.K. Shah; S.W. Meskin; A. Bhargava; J.A. Seedor; R.S. Koplin

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2349. doi:

ARVO Annual Meeting Abstract May 2006

Will the Fortification of Optisol GS® With Voriconazole Reduce the Fungal Contamination Rate of Corneal Donor Rim Cultures?

M.K. Shah; D.C. Ritterband; R. Yang; S.W. Meskin; J.A. Seedor; A. Bhargava; R.S. Koplin

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2351. doi:

ARVO Annual Meeting Abstract May 2005

Will the Fortification of Optisol GS® With Moxifloxacin Reduce the Contamination Rate of Corneal Donor Rim Cultures?

M.K. Shah; D.C. Ritterband; S.M. Meskin; D.E. Shapiro; W. Perez; P. Dahl; J.A. Seedor; R.S. Koplin

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4883. doi:

ARVO Annual Meeting Abstract May 2004

Are BAK–free antibiotics susceptible to bacterial contamination?

T.L. Kaiura; D.C. Ritterband; M.K. Shah; M.K. Rhee; J.A. Seedor

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4912. doi:

ARVO Annual Meeting Abstract May 2004

Increasing Resistance of Endophthalmitis Isolates To Fluorquinolones– A Sixteen Year Review

A.S. Davis; R.C. Gentile; M. Shah; J.A. Seedor; D.C. Ritterband; D. Will

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):517. doi:

ARVO Annual Meeting Abstract May 2003

Microbiologic Analysis of Eyes with Retained Intraocular Foreign Bodies

A.J. Terraciano; D.C. Ritterband; A. Dingley; M. Shah; C. Hsu; J.A. Seedor

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1848. doi:

ARVO Annual Meeting Abstract May 2003

In vitro Sensitivity of Organisms Responsible for Intraocular Foreign Body Associated Endophthalmitis

D.C. Ritterband; A.J. Terraciano; M.K. Shah; A. Dingley; C. Hsu; R.S. Koplin; J.A. Seedor

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):807. doi:

ARVO Annual Meeting Abstract May 2003

Will the Topical Fourth Generation Fluoroquinolones Become the Antibiotics of Choice for Treating Atypical Mycobacteria Related Eye Disease?

M.K. Shah; D.C. Ritterband; A.J. Terraciano; G. Fishman; W. Perez; J. Lawrence; J.A. Seedor

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1459. doi:

ARVO Annual Meeting Abstract May 2003

An In Vitro Comparison of Tobramycin and Gentamicin to Moxifloxacin and Gatifloxacin Using Bacterial Keratitis Isolates

T.M. Harvey; R.P. Kowalski; L.M. Karenchak; D.C. Ritterband; F.S. Mah

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1466. doi:

ARVO Annual Meeting Abstract May 2003

Incidence of Infectious Keratitis After LASIK

C.T. Hsu; D.C. Ritterband; M. Livits; R.S. Koplin; A.J. Terraciano; J.A. Seedor

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):2688. doi:

Advertisement